Newsbenzinga
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
· Published
Article summary
Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
An excerpt from the original article.
Comments —
Loading comments…